Samsung Biologics Launches All‑Cash Tender Offer to Acquire PolyPeptide Group AG
Samsung Biologics’ all‑cash tender offer for PolyPeptide Group AG boosts its peptide‑API expertise, expanding global CDMO services and growth prospects.
2 minutes to read